Hjem › Pulmonal hypertensjon › Florida
Kliniske studier for Pulmonal hypertensjon i Florida
12 studier for Pulmonal hypertensjon søker deltakere på steder i Florida.
Byer i Florida
Offisiell studietekst (engelsk)
Efficacy and Safety Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
- USA017, Gainesville
- USA006, Naples
- USA026, St. Petersburg
- og 1 flere
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 29. sep. 2026 · NCT07179380A Phase 3 Trial of Inhaled Mosliciguat in PH-ILD (PHrontier)
- Clinical Research Site, Kissimmee
RekruttererFase 3
Alder 18 til 85 · Alle kjønn · Oppdatert 11. sep. 2026 · NCT07816185Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension
- AdventHealth Orlando, Orlando
Rekrutterer
Alder 18 og eldre · Alle kjønn · Oppdatert 2. sep. 2026 · NCT06911632A Phase 3 Study to Evaluate the Safety and Efficacy L606 in Participants With PH-ILD
- Tampa General Hospital, Tampa
RekruttererFase 3
Alder 18 til 80 · Alle kjønn · Oppdatert 2. sep. 2026 · NCT07285655A Study of Mosliciguat in Combination With Inhaled Treprostinil in PH-ILD
- Clinical Research Site, Kissimmee
RekruttererFase 2
Alder 18 til 85 · Alle kjønn · Oppdatert 2. sep. 2026 · NCT07333183DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
- University of Florida, Gainesville
- NCH Research Institute, Naples
- Advent Health Medical Group Advanced Lung Disease, Orlando
- og 3 flere
RekruttererObservasjonsstudie
Alder 18 og eldre · Alle kjønn · Oppdatert 26. aug. 2026 · NCT06388421An Open-Label Extension Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
- USA006, Naples
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 13. aug. 2026 · NCT07234032A Study of ROC-101 in Patients With Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated With Interstitial Lung Disease (ILD-PH) (ROCSTAR STUDY)
- Mayo Clinic of Florida, Jacksonville
RekruttererFase 2
Alder 18 til 80 · Alle kjønn · Oppdatert 10. aug. 2026 · NCT07175038Bridge to Lung Transplant With Trans-septal Extra-corporeal Membrane Oxygenation (ECMO) for Right Heart Failure From Pulmonary Hypertension
- Mayo Clinic in Florida, Jacksonville
RekruttererFase 1
Alder 18 til 80 · Alle kjønn · Oppdatert 31. jul. 2026 · NCT06770023An Open-Label ProSpective MultiCENTer Study to Evaluate Safety and Tolerability of Dry Powder Inhaled Treprostinil in PH
- Advent Health, Orlando
- Tampa General Hospital Center of Research Excellence, Tampa
RekruttererObservasjonsstudie
Alder 18 til 80 · Alle kjønn · Oppdatert 26. jun. 2026 · NCT06129240Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure
- Shands at the University of Florida, Gainesville
- Cleveland Clinic Florida, Weston
Rekrutterer
Alder 18 og eldre · Alle kjønn · Oppdatert 10. jun. 2026 · NCT06526195Pulmonary Hypertension Association Registry
- Mayo Clinic Florida, Jacksonville
RekruttererObservasjonsstudie
Alder 0 og eldre · Alle kjønn · Oppdatert 14. nov. 2025 · NCT04071327Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.